3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
6
Lung Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Motor Activity
3
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pathologically Proven Gastrointestinal Malignancy
1
Obesity
1
Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Insulin Resistance
1
Inflammatory Breast Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Interventions
Fluorouracil
218
Leucovorin
201
Oxaliplatin
191
Irinotecan
148
Bevacizumab
107
Capecitabine
93
Cetuximab
89
Folfox protocol
54
Chemotherapy, Adjuvant
34
Panitumumab
30
pembrolizumab
23
Nivolumab
22
Colonoscopy
22
Gemcitabine
20
Magnetic Resonance Spectroscopy
19
Floxuridine
19
IFL protocol
18
Celecoxib
18
Radiotherapy
17
Neoadjuvant Therapy
17
Early Intervention, Educational
17
Drug Therapy
17
Laparoscopy
14
Cyclophosphamide
14
Counseling
14
trifluridine tipiracil drug combination
13
regorafenib
13
XELOX
13
Exercise
13
Erlotinib Hydrochloride
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Colonic Neoplasms
×
Exercise Test
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts